Getein Biotech Inc
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical … Read more
Getein Biotech Inc (603387) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.036x
Based on the latest financial reports, Getein Biotech Inc (603387) has a cash flow conversion efficiency ratio of 0.036x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.90 Million) by net assets (CN¥2.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Getein Biotech Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Getein Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Getein Biotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Getein Biotech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Altek Corp
TW:3059
|
-0.007x |
|
Chief Telecom Inc
TWO:6561
|
0.122x |
|
Zhejiang Netsun Co Ltd
SHE:002095
|
0.015x |
|
Reway Group S.p.A.
F:IR0
|
N/A |
|
Nok Airlines Public Company Limited
OTCGREY:NOKFF
|
0.010x |
|
JOY CITY PPTY HD -10
F:HKP
|
N/A |
|
GDI INTEGR. FAC. SVCS
F:GQN2
|
N/A |
|
Kura Sushi USA Inc
NASDAQ:KRUS
|
0.003x |
Annual Cash Flow Conversion Efficiency for Getein Biotech Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Getein Biotech Inc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.72 Billion | CN¥423.00 Million | 0.155x | +27.89% |
| 2023-12-31 | CN¥2.74 Billion | CN¥333.22 Million | 0.122x | -32.93% |
| 2022-12-31 | CN¥2.66 Billion | CN¥482.96 Million | 0.181x | -4.67% |
| 2021-12-31 | CN¥2.27 Billion | CN¥432.36 Million | 0.190x | +105.44% |
| 2020-12-31 | CN¥2.00 Billion | CN¥185.47 Million | 0.093x | -31.05% |
| 2019-12-31 | CN¥1.68 Billion | CN¥225.73 Million | 0.134x | -0.76% |
| 2018-12-31 | CN¥1.38 Billion | CN¥187.10 Million | 0.135x | -19.10% |
| 2017-12-31 | CN¥1.15 Billion | CN¥191.91 Million | 0.167x | -63.22% |
| 2016-12-31 | CN¥342.96 Million | CN¥155.91 Million | 0.455x | +0.31% |
| 2015-12-31 | CN¥268.60 Million | CN¥121.73 Million | 0.453x | -24.02% |
| 2014-12-31 | CN¥165.19 Million | CN¥98.53 Million | 0.596x | -16.03% |
| 2013-12-31 | CN¥84.06 Million | CN¥59.72 Million | 0.710x | +21.27% |
| 2012-12-31 | CN¥40.63 Million | CN¥23.80 Million | 0.586x | -- |